PAHC vs. BMY
Compare and contrast key facts about Phibro Animal Health Corporation (PAHC) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PAHC or BMY.
Correlation
The correlation between PAHC and BMY is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
PAHC vs. BMY - Performance Comparison
Key characteristics
PAHC:
1.85
BMY:
0.60
PAHC:
3.14
BMY:
1.12
PAHC:
1.38
BMY:
1.14
PAHC:
1.29
BMY:
0.37
PAHC:
12.46
BMY:
1.51
PAHC:
7.66%
BMY:
11.61%
PAHC:
51.78%
BMY:
29.24%
PAHC:
-79.60%
BMY:
-70.62%
PAHC:
-49.58%
BMY:
-24.36%
Fundamentals
PAHC:
$978.97M
BMY:
$111.57B
PAHC:
$0.48
BMY:
-$4.41
PAHC:
1.66
BMY:
1.21
PAHC:
$1.11B
BMY:
$48.30B
PAHC:
$351.02M
BMY:
$32.20B
PAHC:
$107.47M
BMY:
$3.16B
Returns By Period
In the year-to-date period, PAHC achieves a 9.38% return, which is significantly higher than BMY's -0.27% return. Over the past 10 years, PAHC has underperformed BMY with an annualized return of -2.04%, while BMY has yielded a comparatively higher 2.25% annualized return.
PAHC
9.38%
6.79%
22.18%
88.32%
-0.44%
-2.04%
BMY
-0.27%
-2.19%
19.78%
15.06%
0.36%
2.25%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PAHC vs. BMY — Risk-Adjusted Performance Rank
PAHC
BMY
PAHC vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Phibro Animal Health Corporation (PAHC) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PAHC vs. BMY - Dividend Comparison
PAHC's dividend yield for the trailing twelve months is around 2.09%, less than BMY's 4.34% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PAHC Phibro Animal Health Corporation | 2.09% | 2.29% | 4.15% | 3.58% | 2.35% | 2.47% | 1.93% | 1.31% | 1.19% | 1.37% | 1.33% | 0.63% |
BMY Bristol-Myers Squibb Company | 4.34% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% |
Drawdowns
PAHC vs. BMY - Drawdown Comparison
The maximum PAHC drawdown since its inception was -79.60%, which is greater than BMY's maximum drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for PAHC and BMY. For additional features, visit the drawdowns tool.
Volatility
PAHC vs. BMY - Volatility Comparison
Phibro Animal Health Corporation (PAHC) has a higher volatility of 18.68% compared to Bristol-Myers Squibb Company (BMY) at 8.69%. This indicates that PAHC's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
PAHC vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Phibro Animal Health Corporation and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities